CG
Column Group Portfolio holdings
AUM
$65.7M
This Quarter Return
+37.58%
1 Year Return
-5.8%
3 Year Return
-15.66%
5 Year Return
–
10 Year Return
–
AUM
$151M
AUM Growth
+$151M
(+0.51%)
Cap. Flow
-$120M
Cap. Flow
% of AUM
-79.47%
Top 10 Holdings %
Top 10 Hldgs %
100%
Holding
7
New
–
Increased
–
Reduced
2
Closed
1
Top Buys
No buys this quarter
Top Sells
| 1 |
Surrozen
SRZN
|
$82.6M |
| 2 |
Revolution Medicines
RVMD
|
$35.3M |
| 3 |
EFTR
eFFECTOR Therapeutics, Inc. Common Stock
EFTR
|
$2.42M |
Sector Composition
| 1 | Healthcare | 100% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1
RAPT Therapeutics
RAPT
$188M
| $66.6M | 44% | 2,680,621 | – | – |
|
2
Oric Pharmaceuticals
ORIC
$994M
| $32.8M | 21.69% | 3,568,181 | – | – |
|
3
Tenaya Therapeutics
TNYA
$184M
| $30.5M | 20.12% | 9,400,290 | – | – |
|
|
NGM
4
DELISTED
NGM Biopharmaceuticals, Inc. Common Stock
NGM
| $15.6M | 10.29% | 18,136,735 | – | – |
|
|
5
Surrozen
SRZN
$104M
| $5.9M | 3.9% | 627,651 -8,787,144 | -93% | -$82.6M |
|
|
6
Revolution Medicines
RVMD
$7.1B
| $1.32K | ﹤0.01% | 46 -1,230,595 | -100% | -$35.3M |
|
|
EFTR
7
DELISTED
eFFECTOR Therapeutics, Inc. Common Stock
EFTR
| – | – | -4,026,224 | Closed | -$2.42M |
|